• FirefoxTry Yahoo Finance on Firefox »
  •  Dow down 0.08% Nasdaq up 0.22%
    {"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}
     Dow down 0.08% Nasdaq up 0.22%
    {"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}

    Quote Results

    Add Quotes

    SymbolTime & PriceChg & % ChgDay's Low & HighVolumeAvg VolMkt CapChartMore Info
    Nov 27 53.96 +0.24 +0.45% 53.36 54.20 2,981,642 12,267,100 150.74B Sparkline Chart Chart, News, Stats, Options, Board
    No such ticker symbol: REAL-TIMETry Symbol Lookup
    {"s" : "mrk","k" : "t53,l84,c63,p43,g53,h53,v53,j10,c63,l84,p43,a00,a50,b00,b60,g00,h00,t53,v53","o" : "","j" : "c63,l84,p43,t53,v53"}

    Quotes delayed, except where indicated otherwise.

    Recent News

    day and time symbols news headline and source
    Friday November 27, 2015
    Merck KGaA-Pfizer's Avelumab May Get Orphan Status in EU Zacks02:40pm EST
    The 4 Stocks That Balanced the DJIA on Friday at 24/7 Wall St.01:01pm EST
    5 Breakout Trades for Black Friday at TheStreet08:34am EST
    Thursday November 26, 2015
    Keytruda: Hope for Merck’s Immuno-Oncology Franchise Market Realist12:04am EST
    Remicade: A Falling Drug in Merck’s Immunology Franchise Market Realist12:04am EST
    Wednesday November 25, 2015
    Merck & Co., Inc. (MRK): Insiders Are Buying, Should You? at Insider Monkey06:52am EST
    Tuesday November 24, 2015
    Will Merck (MRK) Stock Be Helped by Dividend Hike? at TheStreet01:25pm EST
    Merck Announces Increased Quarterly Dividend Business Wire12:35pm EST
    Merrill Lynch 4 Top Pharmaceutical Dividend Stocks To Own For 2016 at 24/7 Wall St.10:47am EST
    After Pfizer-Allergan Deal, Large Inversions May Be Hard to Find Bloomberg09:15am EST
    This Metric Implies That It Might Be Time to Buy Big Pharma Stocks at Motley Fool07:41am EST
    Monday November 23, 2015
    JAVELIN Series: Clinical Studies of Avelumab Market Realist02:34pm EST
    Avelumab Receives Breakthrough Therapy Designation Market Realist02:34pm EST
    Can Merck & Co. Take Down Gilead Sciences? at Motley Fool10:01am EST
    Pfizer-Allergan Merger May Be Dwarfed By The Merck-Express Scripts Divide at Forbes09:44am EST
    Sunday November 22, 2015
    Pfizer set to buy Allergan for more than $150 bln-sources Reuters06:54pm EST
    Saturday November 21, 2015
    Merck Announces Initial Results for KEYTRUDA® (pembrolizumab) with Novel Immunotherapy Combinations from Three Investigational Studies Presented at the Society for Melanoma Research International Congress Business Wire04:30pm EST
    Gilead Sciences Inc. Has Plenty of Room to Run in Hepatitis C at Motley Fool09:04am EST
    Friday November 20, 2015
    Gilead Sciences: Hepatitis-C Prescriptions Increase at Barrons.com02:14pm EST
    Germany's Merck aims to more than double Africa sales by 2020 at Financial Times09:56am EST
    Merck & Co.'s Cholesterol-Buster Program Isn't (Yet) an Exercise in Futility at Motley Fool07:40am EST